FORA Capital LLC bought a new stake in shares of Veralto Co. (NYSE:VLTO – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 49,655 shares of the company’s stock, valued at approximately $5,554,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in VLTO. Ashton Thomas Securities LLC bought a new position in shares of Veralto in the 3rd quarter valued at approximately $25,000. Goodman Advisory Group LLC acquired a new position in Veralto during the second quarter valued at approximately $26,000. Fairscale Capital LLC bought a new position in shares of Veralto in the second quarter valued at approximately $30,000. Hazlett Burt & Watson Inc. lifted its stake in shares of Veralto by 11,100.0% in the second quarter. Hazlett Burt & Watson Inc. now owns 336 shares of the company’s stock worth $32,000 after buying an additional 333 shares during the last quarter. Finally, Raleigh Capital Management Inc. boosted its holdings in shares of Veralto by 692.3% during the 3rd quarter. Raleigh Capital Management Inc. now owns 309 shares of the company’s stock worth $35,000 after buying an additional 270 shares during the period. Institutional investors and hedge funds own 91.28% of the company’s stock.
Analyst Ratings Changes
A number of research firms have weighed in on VLTO. TD Cowen boosted their target price on shares of Veralto from $95.00 to $100.00 and gave the stock a “hold” rating in a research report on Tuesday, July 30th. Stifel Nicolaus increased their target price on Veralto from $117.00 to $119.00 and gave the company a “buy” rating in a research note on Wednesday, October 16th. BMO Capital Markets lifted their price target on Veralto from $117.00 to $119.00 and gave the stock an “outperform” rating in a research report on Monday, September 30th. UBS Group initiated coverage on Veralto in a research report on Tuesday, August 13th. They issued a “neutral” rating and a $118.00 price objective for the company. Finally, Royal Bank of Canada boosted their target price on shares of Veralto from $108.00 to $111.00 and gave the stock a “sector perform” rating in a research report on Friday, October 25th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $108.27.
Insider Activity
In other news, SVP Surekha Trivedi sold 752 shares of the firm’s stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $102.91, for a total transaction of $77,388.32. Following the completion of the sale, the senior vice president now owns 10,413 shares of the company’s stock, valued at approximately $1,071,601.83. This trade represents a 6.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jennifer Honeycutt sold 13,191 shares of Veralto stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $111.98, for a total transaction of $1,477,128.18. Following the completion of the transaction, the chief executive officer now owns 138,546 shares of the company’s stock, valued at $15,514,381.08. This trade represents a 8.69 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 28,639 shares of company stock worth $3,175,803. Company insiders own 0.31% of the company’s stock.
Veralto Stock Performance
Shares of NYSE VLTO traded up $0.58 during trading hours on Wednesday, reaching $108.54. The stock had a trading volume of 46,210 shares, compared to its average volume of 1,534,750. Veralto Co. has a twelve month low of $72.85 and a twelve month high of $115.00. The company has a debt-to-equity ratio of 1.35, a current ratio of 2.13 and a quick ratio of 1.87. The business’s fifty day moving average is $108.06 and its two-hundred day moving average is $104.67. The company has a market cap of $26.84 billion and a price-to-earnings ratio of 33.32.
Veralto (NYSE:VLTO – Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $0.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.04. Veralto had a net margin of 15.69% and a return on equity of 52.85%. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter in the prior year, the company posted $0.75 EPS. The business’s revenue was up 4.7% on a year-over-year basis. As a group, research analysts expect that Veralto Co. will post 3.48 EPS for the current year.
Veralto Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Friday, September 27th were issued a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend was Friday, September 27th. Veralto’s payout ratio is 11.11%.
About Veralto
Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.
Featured Stories
- Five stocks we like better than Veralto
- 3 Monster Growth Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Invest in 5G? How to Invest in 5G Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Golden Cross Stocks: Pattern, Examples and Charts
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Veralto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veralto and related companies with MarketBeat.com's FREE daily email newsletter.